Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines – a matched cohort study in France
View ORCID ProfileVincent Auvigne, View ORCID ProfileCynthia Tamandjou, View ORCID ProfileJustine Schaeffer, View ORCID ProfileSophie Vaux, Isabelle Parent du Chatelet
doi: https://doi.org/10.1101/2023.03.17.23287411
Vincent Auvigne
1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, Public Health France. F-94415 Saint-Maurice, France
Cynthia Tamandjou
1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, Public Health France. F-94415 Saint-Maurice, France
Justine Schaeffer
1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, Public Health France. F-94415 Saint-Maurice, France
Sophie Vaux
1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, Public Health France. F-94415 Saint-Maurice, France
Isabelle Parent du Chatelet
1Direction des maladies infectieuses - Unité infections respiratoires et vaccination, Santé publique France, Public Health France. F-94415 Saint-Maurice, France

Article usage
Posted March 18, 2023.
Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines – a matched cohort study in France
Vincent Auvigne, Cynthia Tamandjou, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Chatelet
medRxiv 2023.03.17.23287411; doi: https://doi.org/10.1101/2023.03.17.23287411
Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines – a matched cohort study in France
Vincent Auvigne, Cynthia Tamandjou, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Chatelet
medRxiv 2023.03.17.23287411; doi: https://doi.org/10.1101/2023.03.17.23287411
Subject Area
Subject Areas
- Addiction Medicine (427)
- Allergy and Immunology (753)
- Anesthesia (220)
- Cardiovascular Medicine (3281)
- Dermatology (274)
- Emergency Medicine (478)
- Epidemiology (13336)
- Forensic Medicine (19)
- Gastroenterology (896)
- Genetic and Genomic Medicine (5127)
- Geriatric Medicine (479)
- Health Economics (780)
- Health Informatics (3250)
- Health Policy (1137)
- Hematology (427)
- HIV/AIDS (1012)
- Medical Education (475)
- Medical Ethics (126)
- Nephrology (521)
- Neurology (4898)
- Nursing (261)
- Nutrition (725)
- Oncology (2515)
- Ophthalmology (722)
- Orthopedics (280)
- Otolaryngology (346)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (537)
- Pediatrics (1297)
- Primary Care Research (554)
- Public and Global Health (7482)
- Radiology and Imaging (1700)
- Respiratory Medicine (979)
- Rheumatology (478)
- Sports Medicine (424)
- Surgery (545)
- Toxicology (71)
- Transplantation (235)
- Urology (203)